both the in vitro and in vivo studies revealed that hsa_circ_101280 largely facilitated the tumorigenesis of HCC, characterized by the promoted proliferation and suppressed apoptosis of HCC cells, by sponging miR-375 and upregulating JAK2.
Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2.